Bristol Myers Squibb
@mirati.com
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Bristol Myers Squibb's Company Logos
Bristol Myers Squibb's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#5192B2
Hippie Blue
81, 146, 178
200, 39, 51
54, 18, 0, 30
#DF95DD
Light Orchid
223, 149, 221
302, 54, 73
0, 33, 1, 13
#363131
Mine Shaft
54, 49, 49
0, 5, 20
0, 9, 9, 79
About Bristol Myers Squibb
Mirati Therapeutics is a precision oncology company that focuses on advancing drug discovery and research to deliver novel therapeutics targeting the genetic and immunologic drivers of cancer. Led by a team of experienced executives, Mirati is committed to excellence in developing innovative treatments. Dr.
Charles Baum, Interim CEO and President, founded Mirati in 2012 and has transformed the company into a leader in precision oncology. Dr. James Christensen serves as the Chief Scientific Officer and is responsible for driving drug discovery and translational research.
Ben Hickey, the Chief Commercial Officer, brings almost 20 years of industry experience to lead the commercial and medical affairs functions. John Moriarty, the Chief Legal Officer, has over 25 years of legal and business leadership in the biotech industry. With a strong leadership team and a focus on precision medicine, Mirati Therapeutics is dedicated to revolutionizing cancer treatment
Company type
Public Company
Year founded
2013
Company size
201-500 employees
Related Brands
Tags
Biopharmaceutical company
Oncology therapeutics
Immunology therapeutics
Clinical trials
Patient support resources
